Literature DB >> 26759326

Ultrasound findings in EHEC-associated hemolytic-uremic syndrome and their clinical relevance.

Ansgar Reising1, Carsten Hafer2,3, Marcus Hiss2, Jan T Kielstein2,4, Jan Menne2, Faikah Gueler2, Jan Beneke2, Silvia Linnenweber-Held2, Hermann Haller2, Gunilla Einecke2.   

Abstract

PURPOSE: Hemolytic-uremic syndrome (HUS) and acute kidney injury (AKI) after infection with Shiga toxin-producing E. coli (EHEC) are clinically important complications. We present a retrospective analysis of abdominal ultrasound findings in patients with HUS caused by EHEC O104:H4 (n = 41).
METHODS: We assessed intrarenal resistance indices and quantitated kidney parenchymal density by the kidney/liver intensity ratio using computer-based image analysis. Findings in EHEC-HUS were compared to those in AKI due to other reasons (n = 60) and 19 healthy volunteers.
RESULTS: Kidneys in EHEC-HUS patients showed severe morphologic changes with striking parenchymal echogenicity. Renal resistance index was increased in HUS (0.80 ± 0.08) compared to patients with AKI due to glomerulopathy (0.69 ± 0.08, p < 0.001) or patients with other causes of AKI (0.74 ± 0.10, p < 0.01). Parenchymal density was increased in EHEC-HUS (1.39 ± 0.35) compared to AKI due to glomerulopathy (1.18 ± 0.20, p < 0.05), other causes of AKI (1.12 ± 0.21, p < 0.001) and healthy controls (0.86 ± 0.16, p < 0.001). Patients with atypical HUS showed increased parenchymal density (1.43 ± 0.37), similar to those with EHEC-HUS. EHEC-HUS patients who required dialysis treatment had higher parenchymal density (1.58 ± 0.08) compared to those without dialysis (1.14 ± 0.05, p = 0.0004). Extrarenal findings in EHEC-HUS included hepatomegaly (45%), splenomegaly (39%), ascites (84%) and pleural effusions (84%).
CONCLUSIONS: Patients with EHEC-HUS had a characteristic constellation of morphologic abnormalities on ultrasound examination, indicating that the effects of HUS are not limited to the kidney but include multiple organs, possibly mediated through systemic capillary leakage. Assessment of parenchymal echogenicity contributes to the differential diagnosis of AKI. Parameters reflecting renal perfusion correlated with severity of disease and thus may have prognostic value in future patient evaluation.

Entities:  

Keywords:  Acute kidney injury; EHEC; Hemolytic-uremic syndrome; Image analysis; Resistance index; Ultrasound

Mesh:

Year:  2016        PMID: 26759326     DOI: 10.1007/s11255-015-1194-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  30 in total

Review 1.  B-mode sonography in acute renal failure.

Authors:  W Charles O'Neill
Journal:  Nephron Clin Pract       Date:  2006-03-10

Review 2.  Atypical hemolytic-uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

3.  Hemolytic-uremic syndrome: intrarenal arterial Doppler patterns as a useful guide to therapy.

Authors:  H B Patriquin; S O'Regan; P Robitaille; H Paltiel
Journal:  Radiology       Date:  1989-09       Impact factor: 11.105

4.  Cortical echogenicity in the hemolytic uremic syndrome: clinical correlation.

Authors:  P L Choyke; E G Grant; F A Hoffer; L Tina; S Korec
Journal:  J Ultrasound Med       Date:  1988-08       Impact factor: 2.153

Review 5.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  Sonography of the kidneys in hemolytic uremic syndrome.

Authors:  P J Kenney; R E Brinsko; D V Patel; R E Spitzer; F M Farrar
Journal:  Invest Radiol       Date:  1986-07       Impact factor: 6.016

7.  Renal parenchymal disease: sonographic-histologic correlation.

Authors:  H Hricak; C Cruz; R Romanski; M H Uniewski; N W Levin; B L Madrazo; M A Sandler; W R Eyler
Journal:  Radiology       Date:  1982-07       Impact factor: 11.105

8.  Pleural effusion complicating acute peritoneal dialysis in hemolytic uremic syndrome.

Authors:  L Butani; M S Polinsky; B A Kaiser; H J Baluarte
Journal:  Pediatr Nephrol       Date:  1998-11       Impact factor: 3.714

Review 9.  [Ultrasonography of the kidney and renal vessels. I. Normal findings, inherited and parenchymal diseases].

Authors:  J Radermacher
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

10.  Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.

Authors:  Jan Menne; Martin Nitschke; Robert Stingele; Mariam Abu-Tair; Jan Beneke; Jörn Bramstedt; Jan P Bremer; Reinhard Brunkhorst; Veit Busch; Reinhard Dengler; Günther Deuschl; Klaus Fellermann; Helmut Fickenscher; Christoph Gerigk; Alexander Goettsche; Jobst Greeve; Carsten Hafer; Friedrich Hagenmüller; Hermann Haller; Stefan Herget-Rosenthal; Bernd Hertenstein; Christina Hofmann; Melanie Lang; Jan T Kielstein; Ulrich C Klostermeier; Johannes Knobloch; Markus Kuehbacher; Ulrich Kunzendorf; Hendrik Lehnert; Michael P Manns; Tobias F Menne; Tobias N Meyer; Claus Michael; Thomas Münte; Christine Neumann-Grutzeck; Jens Nuernberger; Hermann Pavenstaedt; Leyla Ramazan; Lutz Renders; Jonas Repenthin; Wolfgang Ries; Axel Rohr; Lars Christian Rump; Ola Samuelsson; Friedhelm Sayk; Bernhard M W Schmidt; Sabine Schnatter; Harald Schöcklmann; Stefan Schreiber; Cay U von Seydewitz; Jürgen Steinhoff; Sylvia Stracke; Sebastian Suerbaum; Andreas van de Loo; Martin Vischedyk; Karin Weissenborn; Peter Wellhöner; Monika Wiesner; Sebastian Zeissig; Jürgen Büning; Mario Schiffer; Tanja Kuehbacher
Journal:  BMJ       Date:  2012-07-19
View more
  1 in total

1.  Diffusion-weighted imaging of the kidneys in haemolytic uraemic syndrome.

Authors:  Jochen Herrmann; Ulrich Wenzel; Stephanie Galler; Bjoern P Schoennagel; Jasmin D Busch; Magdalini Tozakidou; Kay U Petersen; Michaela Joekel; Peter Bannas; Jin Yamamura; Michael Groth; Gerhard Adam; Christian R Habermann
Journal:  Eur Radiol       Date:  2017-05-12       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.